Rapid prostate cancer test FRPS 025

oncologyproteinPSA

Fast and accurate quantitative in vitro diagnostic of Prostate-specific antigen (PSA) KEY FEATURES & BENEFITS - Cleared from FDA 510(k) - Measures the level of Prostate Specific Antigen (PSA) to monitor (or manage) patients with prostate cancer - Fast and accurate quantitative in vitro diagnostic of the protein in human serum or plasma based on the lab-on-a-chip technology - Cartridge designed for insertion into the FREND™ System in vitro quantitative measurement of PSA PSA Plus FREND Cartridge PSA Plus Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene. It is a member of the kallikrein-related peptidase family and is secreted by the epithelial cells of the prostate gland. and also, PSA is produced for the ejaculate, where it liquefies semen in the seminal coagulum and allows sperm to swim freely. It is also believed to be instrumental in dissolving cervical mucus, allowing the entry of sperm into the uterus. ADVANTAGE 01 Check the quantitative result of the PSA Plus the most fastly ADVANTAGE 02 Superior Accuracy FREND PSA Plus shows a high correlation with Predicate device AMR 0.05 ~ 25 ng / mL (EU), 0.08 ~ 25 ng/mL (US) Package 25 tests Storage temperature 2 ~ 8 °C